Oramed Pharmaceuticals
ORMP
#9127
Rank
NZ$0.19 B
Marketcap
NZ$4.96
Share price
1.42%
Change (1 day)
14.69%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): NZ$1.44

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$1.41. In 2024 the company made an earnings per share (EPS) of NZ-$0.83 a decrease over its 2023 EPS that were of NZ$0.24.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.44-271.88%
2024NZ-$0.83-442.86%
2023NZ$0.24-114.89%
2022NZ-$1.6420.51%
2021NZ-$1.3639.29%
2020NZ-$0.97-31.71%
2019NZ-$1.43-4.65%
2018NZ-$1.508.86%
2017NZ-$1.37-9.2%
2016NZ-$1.5129.85%
2015NZ-$1.178.06%
2014NZ-$1.085.08%
2013NZ-$1.033.51%
2012NZ-$0.99137.5%
2011NZ-$0.42-60%
2010NZ-$1.04-0%
2009NZ-$1.04-16.67%
2008NZ-$1.25-25%
2007NZ-$1.67700%
2006NZ-$0.21303.56%
2005NZ-$0.05172

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ-$10.33-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$6.11 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$6.45 357.49%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
NZ-$0.52-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
NZ-$0.33-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA